Fidelity Management & Research Co recently announced the acquisition of new stake in Glaukos Corporation (NYSE:GKOS). The institutional investor has increased its shareholding in the Healthcare company by 57.85% to 5.0 million shares with purchase of 1.83 million shares. This fresh investment now brings its stake to 10.24% valued currently at $397.21 million. In addition, Invesco Advisers, Inc. raised its holdings by 0.39 million to 1.16 million shares.
Currently, there are 47.75M common shares owned by the public and among those 46.66M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 96 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 40 of these insider trades were purchases, accounting for 381,356 shares. Insider sales of the common stock occurred on 56 occasions, with total insider shares sold totaling 270,419 shares.
The top 3 mutual fund holders in Glaukos Corporation are iShares Core S&P Small Cap ETF, Brown Capital Management – Small, and Vanguard Total Stock Market ETF. iShares Core S&P Small Cap ETF owns 3.26 million shares of the company’s stock, all valued at over $259.17 million. The company sold 11137.0 shares recently to bring their total holdings to about 6.68% of the shares outstanding. Vanguard Total Stock Market ETF bought 1661.0 shares to bring its total holdings to over 1.45 million shares at a value of $115.42 million. Vanguard Total Stock Market ETF now owns shares totaling to 2.98% of the shares outstanding.
However, the script later moved the day high at 93.55, down -0.72%. The company’s stock has a 5-day price change of 3.71% and 36.54% over the past three months. GKOS shares are trading 16.44% year to date (YTD), with the 12-month market performance up to 90.73% higher. It has a 12-month low price of $44.26 and touched a high of $94.12 over the same period. GKOS has an average intraday trading volume of 715.53K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.97%, 26.51%, and 35.55% respectively.
Institutional ownership of Glaukos Corporation (NYSE: GKOS) shares accounts for 105.00% of the company’s 47.75M shares outstanding. Mutual fund holders own 36.18%, while other institutional holders and individual stakeholders account for 68.95% and 31.76% respectively.
It has a market capitalization of $4.52B and a beta (3y monthly) value of 1.11. The earnings-per-share (ttm) stands at -$2.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.97% over the week and 3.84% over the month.
Analysts forecast that Glaukos Corporation (GKOS) will achieve an EPS of -$0.54 for the current quarter, -$0.55 for the next quarter and -$1.91 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.6 while analysts give the company a high EPS estimate of -$0.47. Comparatively, EPS for the current quarter was -$0.53 a year ago. Earnings per share for the fiscal year are expected to decrease by -2.31%, and 14.83% over the next financial year. EPS should grow at an annualized rate of 8.00% over the next five years, compared to -278.26% over the past 5-year period.
Looking at the support for the GKOS, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on December 21, 2023, with the firm’s price target at $66-$91.
